Efg Capital International Corp. »

Neurocrine Biosciences shares owned by Efg Capital International Corp.

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Efg Capital International Corp. from 13F filings

Historical chart of Efg Capital International Corp. investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Efg Capital International Corp. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Efg Capital International Corp.

Quarter filed Position value Share count Share price at filing
2023-06-30 $296k 3.1k 94.30

More positions owned by Efg Capital International Corp.

Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Amazon (AMZN)
Mastercard Incorporated Cl A (MA)
UnitedHealth (UNH)
Verisk Analytics (VRSK)
Alphabet Cap Stk Cl C (GOOG)
Johnson & Johnson (JNJ)
Pepsi (PEP)
Cme (CME)
Adobe Systems Incorporated (ADBE)
Tesla Motors (TSLA)
Netflix (NFLX)
JPMorgan Chase & Co. (JPM)

View all positions for Efg Capital International Corp.

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
Jpmorgan Chase & Co
Morgan Stanley
Bellevue Group
T. Rowe Price Associates
Geode Capital Management
Henderson Group
Dodge & Cox
Wellington Management Company
DSM Capital Partners
Brown Advisory Holdings Incorporated
Pictet Asset Management Holding SA
Rock Springs Capital Management
Armistice Capital

View all funds holding Neurocrine Biosciences